Global Intra-Uterine Contraceptive Devices Market, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), Product Type (Mirena, Skyla, Paragard, Essure, Levosert, Others), End User (Hospitals, Gynecology Clinics, Community Health Care Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Intra-Uterine Contraceptive Devices
Intra-uterine contraceptive devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5.74 billion by 2028 and will grow at a CAGR of 4.20% in the above mentioned forecast period.
An intrauterine contraceptive device is a type of a medical device, which is inserted in the uterus to put a stop to conception. A plastic string is attached to the end of the device to confirm correct placement and its exclusion.
The rapid increase in the number of unintended pregnancies is amongst the significant factors expected to fuel the growth and demand of intra-uterine contraceptive devices market. In addition, the various favorable government initiatives for spreading awareness and encouraging the use of effective contraceptive methods are also anticipated to push the growth in the global intra-uterine contraceptive devices market over the forecast period of 2021 to 2028. Likewise, the implementation of affordable care is also projected to lift the growth of the market. Furthermore, the increase in awareness regarding pregnancy as well as the less side-effects associated with intrauterine contraceptive devices are also expected to act as significant factors which will flourish the growth of the intra-uterine contraceptive devices market.
The rapid increase in technological innovations and the emergence of advanced intrauterine contraceptive devices (IUCDs) with high accuracy are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the stringent regulations and reimbursement policies as well as the various side effects related with implantation of intrauterine contraceptive devices such as intrauterine pregnancy and pelvic inflammatory disease are estimated to limit the growth of the intra-uterine contraceptive devices market. Whereas, the high risks coupled with intrauterine contraceptive devices can challenge the growth of the intra-uterine contraceptive devices market.
This intra-uterine contraceptive devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on intra-uterine contraceptive devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Intra-Uterine Contraceptive Devices Market Scope and Market Size
Intra-uterine contraceptive devices market is segmented on the basis of type, product type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the intra-uterine contraceptive devices market is segmented into hormonal intrauterine device and copper intrauterine device.
- Intra-uterine contraceptive devices market can is segmented on the basis of product type into mirena, skyla, paragard, essure, levosert and others.
- The end user segment of intra-uterine contraceptive devices market is segmented into hospitals, gynecology clinics, community health care centers and others.
Intra-Uterine Contraceptive Devices Market Country Level Analysis
Intra-uterine contraceptive devices market is analyzed and market size insights and trends are provided by country, type, product type and end user as referenced above.
The countries covered in the intra-uterine contraceptive devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the intra-uterine contraceptive devices market owing to the rise in awareness regarding benefits of intrauterine contraceptive devices (IUCDs) along with the increase in healthcare expenditure. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rapid rise in government initiatives for population control in emerging countries such as India and China.
The country section of the intra-uterine contraceptive devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Intra-uterine contraceptive devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intra-uterine contraceptive devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intra-uterine contraceptive devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Intra-Uterine Contraceptive Devices Market Share Analysis
Intra-uterine contraceptive devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to intra-uterine contraceptive devices market.
The major players covered in the intra-uterine contraceptive devices market report are Teva Pharmaceutical Industries Ltd., Bayer, EUROGINE, S.L., CooperSurgical Inc., Pfizer Inc., HLL Lifecare Limited, OCON Medical Ltd., SMB Corporation, Meril Life Sciences Pvt. Ltd., Mona Lisa, Prosan International BV, Melbea Innovations, Allergan, Merck & Co., Inc., DKT International, Krishco Medical Products Pvt. Ltd., Medisafe Distribution Inc., Medicines360, Pregna International Limited and Egemen International, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Intra-Uterine Contraceptive Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.